Dompe pharma SPA

Oculis has presented positive mid-stage data on the third compound in its pipeline, OCS-05, which demonstrates its potential as the first neuroprotective treatment for a number of optic nerve disorder

Another year, another set of pandemic restrictions and disruptions. 2022 was when much of the Chinese healthcare sector, both small and large, domestic and international firms, felt the chill of Beiji

In Vitro Diagnostics Acquisitions bioMerieux SA Trinity Biotech PLC For approximately €76.8mm ($60mm) (including assets, fees, and earn-outs), bioMerieux has sold its hemostasis product line to diag